DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The other chromosome 22 homologue carries a duplication of the Velocardiofacial/DiGeorge syndrome (VCFS/DGS) region.
|
16708226 |
2006 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
We can partially rescue one salient feature of DGS in Crkl+/-;Tbx1+/- embryos by genetically reducing the amount of RA produced in the embryo.
|
16399080 |
2006 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
We can partially rescue one salient feature of DGS in Crkl+/-;Tbx1+/- embryos by genetically reducing the amount of RA produced in the embryo.
|
16399080 |
2006 |
Shprintzen syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome.
|
16399080 |
2006 |
Shprintzen syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
FISH studies using 4 locus-specific DNA probes in the 22q11.2 region (N25 probe to detect the D22S75 locus within the velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS) critical region, a clone to detect the Bid locus just distal to the cat eye syndrome (CES) critical region and two clones 77H2 and 109L3 to detect the proximal end of the CES critical region, (CECR2 and CECR7), did not reveal any hybridization signal with the marker chromosome.
|
16915592 |
2006 |
Shprintzen syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy.
|
17000704 |
2006 |
Shprintzen syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The differentially deleted regions contain several hypothetical proteins and UniGene clusters and may partially explain the clinical heterogeneity observed in DGS/VCFS patients with the 3-Mb common deletion.
|
16307865 |
2006 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
By providing functional data to indicate loss-of-function produced by the 1223delC TBX1 mutation, our results provide strong support for the conclusion that TBX1 mutations can cause DGS in humans.
|
15703190 |
2005 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
PRODH maps to 22q11 in the region deleted in the velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS) and encodes proline oxidase (POX), a mitochondrial inner-membrane enzyme that catalyzes the first step in the proline degradation pathway.
|
15662599 |
2005 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
In humans, TBX1 is implicated in the etiology of the DiGeorge syndrome.
|
15652707 |
2005 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cytogenetic and FISH analysis was performed in 139 patients to detect the pathognomonic of Di George/ Velocardiofacial syndrome (DGS/VFCS) deletion 22q11.2.
|
15523900 |
2005 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The DiGeorge critical region 6 (DGCR6) gene exists in two highly homologous copies (DGCR6 and DGCR6L) on chromosome 22q11 and is deleted in patients with velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS).
|
15821931 |
2005 |
DiGeorge Syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
By providing functional data to indicate loss-of-function produced by the 1223delC TBX1 mutation, our results provide strong support for the conclusion that TBX1 mutations can cause DGS in humans.
|
15703190 |
2005 |
Shprintzen syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cytogenetic and FISH analysis was performed in 139 patients to detect the pathognomonic of Di George/ Velocardiofacial syndrome (DGS/VFCS) deletion 22q11.2.
|
15523900 |
2005 |
Shprintzen syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The DiGeorge critical region 6 (DGCR6) gene exists in two highly homologous copies (DGCR6 and DGCR6L) on chromosome 22q11 and is deleted in patients with velo-cardio-facial syndrome/DiGeorge syndrome (VCFS/DGS).
|
15821931 |
2005 |
Shprintzen syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
PRODH maps to 22q11 in the region deleted in the velocardiofacial syndrome/DiGeorge syndrome (VCFS/DGS) and encodes proline oxidase (POX), a mitochondrial inner-membrane enzyme that catalyzes the first step in the proline degradation pathway.
|
15662599 |
2005 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract.
|
15175244 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Schizophrenia (SCZD) or schizoaffective disorders are quite common features in patients with DiGeorge/velo-cardio-facial syndrome (DGS/VCFS) as a result of chromosome 22q11.2 aploinsufficiency.
|
15532024 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Children with 22q11.2 microdeletions (Velocardiofacial Syndrome; VCFS) have previously been shown to exhibit learning deficits and elevated rates of psychopathology.
|
15788257 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
The Tbx1 genetic pathway and the cell biology of tissues contributing to pharyngeal arch arteries and cardiac outflow tract are the foundation for understanding congenital heart disease in DiGeorge syndrome.
|
15096950 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors.
|
15469978 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Chromosome 22q11.2 deletions are found in almost 90% of patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS).
|
14681306 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients.
|
15190012 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
Interestingly, bacterial artificial chromosome (BAC) transgenic mice overexpressing human TBX1 and three other transgenes, had similar malformations as VCFS/DGS patients.
|
15190012 |
2004 |
DiGeorge Syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Deletions of chromosome 22q11.2 are found in the vast majority of patients with DiGeorge/velocardiofacial syndrome (DGS/VCFS).
|
14708107 |
2004 |